Fosavance 70mg Tablet
PDF Leaflet Revision Date: 11 June 2015
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of post-menopausal osteoporosis to reduce fracture risk.
Dosage (summary)
One tablet (70 mg/5600 I.U.) once weekly, taken 30 mins before food with water.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Not studied in pregnancy or breastfeeding; contraindicated.
Key Drug Interactions
- Calcium supplements
- Antacids
- Oral medications
Contraindications
- Oesophageal abnormalities
- Inability to sit upright
- Hypocalcaemia
- Severe renal insufficiency
- Pregnancy
- Lactation
Common side effects
- Headache
- Abdominal pain
- Dyspepsia
- Musculoskeletal pain
Counselling Points
- Take with a full glass of water
- Do not lie down for 30 mins after taking
- Report any swallowing difficulties or chest pain
Serious warnings
- Oesophageal irritation
- Gastric ulcers
- Osteonecrosis of the jaw
Important Disclaimer
The Fosavance 70mg Tablet professional information leaflet below is the property of Organon South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
